Creating a device to quickly detect SARS-CoV-2 in the air
Development of a handheld rapid air sensing system to monitor and quantify SARS-CoV-2 in aerosols in real-time
This study is working on a handy device that can quickly check the air for the presence of the COVID-19 virus, making it easier for places like schools and offices to stay safe as they reopen.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Genendeavor, LLC NIH-funded |
| Lab location | 1 site (Hayward, UNITED STATES) |
| Project ID | NIH-10273983 on NIH RePORTER |
What this research studies
This research focuses on developing a handheld device that can monitor and quantify the presence of SARS-CoV-2 in aerosol particles in real-time. By utilizing advanced technologies such as rapid-kinetic chemical auto-ligation and solid-state electronics, the project aims to provide a simple and efficient way to detect the virus in the air, which is crucial for managing airborne transmission risks as communities reopen. The device will allow for immediate results without the need for complex laboratory equipment, making it accessible for use in various settings like schools and workplaces.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals in community settings, such as schools and workplaces, where monitoring air quality for SARS-CoV-2 is essential.
Not a fit: Patients who are not in environments where aerosol transmission is a concern may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance the ability to monitor and control the spread of COVID-19 in public spaces.
How similar studies have performed: While there have been advancements in air monitoring technologies, this specific approach to real-time detection of SARS-CoV-2 in aerosols is novel and has not been extensively tested.
Where this research is happening
Hayward, UNITED STATES
- Genendeavor, LLC — Hayward, United States (Active)
Researchers
- Principal investigator: Mancebo, Ricardo — Genendeavor, LLC
- Study coordinator: Mancebo, Ricardo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.